Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe ; volume:12 ; number:1 ; day:4 ; month:2 ; year:2013 ; pages:1-9 ; date:12.2013
Lipids in health and disease ; 12, Heft 1 (4.2.2013), 1-9, 12.2013
- Urheber
-
Yamazaki, Daisuke
- Beteiligte Personen und Organisationen
-
Ishida, Masaru
Watanabe, Hiroyuki
Nobori, Kiyoshi
Oguma, Yasunori
Terata, Yutaka
Koyama, Takashi
Iino, Kenji
Kosaka, Toshimitsu
Itō, Hiroshi
SpringerLink (Online service)
- DOI
-
10.1186/1476-511X-12-9
- URN
-
urn:nbn:de:1111-2016061014490
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yamazaki, Daisuke
- Ishida, Masaru
- Watanabe, Hiroyuki
- Nobori, Kiyoshi
- Oguma, Yasunori
- Terata, Yutaka
- Koyama, Takashi
- Iino, Kenji
- Kosaka, Toshimitsu
- Itō, Hiroshi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
Aktivierung der erythrozytären NO-Synthase durch Rosuvastatin
Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
Rosuvastatin cocrystals: an attempt to modulate physicochemical parameters
An efficient approach to the key intermediate of rosuvastatin
β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats
Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
The influence of the intestinal microflora to the efficacy of Rosuvastatin
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
Aktivierung der erythrozytären NO-Synthase durch Rosuvastatin
Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
Rosuvastatin cocrystals: an attempt to modulate physicochemical parameters
An efficient approach to the key intermediate of rosuvastatin
β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats
Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
The influence of the intestinal microflora to the efficacy of Rosuvastatin
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
Aktivierung der erythrozytären NO-Synthase durch Rosuvastatin
Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
Rosuvastatin cocrystals: an attempt to modulate physicochemical parameters
An efficient approach to the key intermediate of rosuvastatin
β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats
Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report